Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remifentanil sedation for outpatient endoscopic procedures
2008-002106-19Phase 4Terminated
- Sponsor
- Chelsea and Westminster Hospital NHS Foundation Trust
- Start
- May 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remifentanil in anxiety disorder (2 arms), sponsored by Chelsea and Westminster Hospital NHS Foundation Trust. Primary endpoint: Patient recovery time (Aldrete score). Started May 2008; status: terminated.
02
Drugs
remifentanil
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on 2008-002106-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002106-19.